SRRK insider ownership: who sold, why, and what they still hold

What stands out

Routine activity: 45% of sales were under disclosed plans, and no insider sold more than 1% of vested holdings.

A share of stake is shown for 0 of the 13 officers and directors who sold. 16 are left out

Left out: David Hallal, Akshay Vaishnaw, Vikas Sinha, Keith Woods, Srinivas Akkaraju, Junlin Ho, Caryn Parlavecchio, Mo Qatanani, Jing Marantz, Tracey Sacco, Michael Gilman, Katie Peng, Jeffrey Flier, Kristina Burow, Joshua Reed and Richard Brudnick (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Mo Qatanani

Chief Scientific Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$8.6M91% planned, 9% to cover taxes

David Hallal

Chief Executive Officer, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$4.0MTo cover taxes

Akshay Vaishnaw

President of R&D, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$1.5MTo cover taxes

Vikas Sinha

Chief Financial Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$1.2MTo cover taxes

Keith Woods

Chief Operating Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$1.2MTo cover taxes

All 13 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

Sep 24, 2026Keith Woods gave away 48K shares as a gift.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Keith Woods Chief Operating Officer	48,034	n/a	n/a	n/a	Sep 24, 2026	Sep 25, 2026

Sep 21, 2026David Hallal gave away 37K shares as a gift.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
David Hallal Chief Executive Officer, Director	36,652	n/a	n/a	n/a	Sep 21, 2026	Sep 23, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Outside holders, reported separately

Invus Public Equities, L.P., Srinivas Akkaraju and Kristina Burow reported no open-market sales in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Scholar Rock Holding Corp CEO selling stock?

Yes. David Hallal sold 88K shares ($4.0M) in the past 12 months, none of it under a trading plan disclosed in the filings.

Why are Scholar Rock Holding Corp insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 45% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 55% were to cover taxes. A trading plan schedules sales in advance.

Are any Scholar Rock Holding Corp insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold13 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Mo Qatanani Chief Scientific Officer	$8.6M 189K shares	Not confirmed share of stake is being verified. Why	91% under a disclosed plan, 9% to cover taxes
David Hallal Chief Executive Officer, Director	$4.0M 88K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Akshay Vaishnaw President of R&D, Director	$1.5M 33K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Vikas Sinha Chief Financial Officer	$1.2M 27K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Keith Woods Chief Operating Officer	$1.2M 27K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Junlin Ho General Counsel	$802K 18K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Caryn Parlavecchio CHRO	$714K 16K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Jing Marantz Chief Medical Officer	$451K 10K shares	Not confirmed share of stake is being verified. Why	To cover taxes
Katie Peng Director	$338K 6.5K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Jeffrey Flier Director	$164K 3.1K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Joshua Reed Director	$164K 3.1K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Kristina Burow Director	$164K 3.1K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Michael Gilman Director	$137K 2.5K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

Board members representing outside shareholders, reported separately: Srinivas Akkaraju, Kristina Burow. Details

Outside holder, reported separately: Invus Public Equities, L.P. (a 10% owner, not part of management). No open-market sales reported in the period. Latest filing

The full ownership picture0 of 16 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 16, 2025

Sold

Held Oct 16, 2026

Still held

David Hallal

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for David Hallal are complete.

Chief Executive Officer, Director

n/a

−88K

n/a

Vesting, gifts, unvested awards and holding lines for David Hallal

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Hallal are complete; balances and unit counts will be added when the check is finished.

−37Kgifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
275,167	$32.91	May 2, 2035	$6.0M

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Akshay Vaishnaw

President of R&D, Director

n/a

−33K

n/a

Vesting, gifts, unvested awards and holding lines for Akshay Vaishnaw

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Akshay Vaishnaw are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
110,067	$32.91	May 2, 2035	$2.4M

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Vikas Sinha

Chief Financial Officer

n/a

−27K

n/a

Vesting, gifts, unvested awards and holding lines for Vikas Sinha

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Vikas Sinha are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
110,067	$32.91	May 2, 2035	$2.4M

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Keith Woods

Chief Operating Officer

n/a

−27K

n/a

Vesting, gifts, unvested awards and holding lines for Keith Woods

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Keith Woods are complete; balances and unit counts will be added when the check is finished.

−48Kgifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
110,067	$32.91	May 2, 2035	$2.4M

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Srinivas Akkaraju

Director

n/a

Vesting, gifts, unvested awards and holding lines for Srinivas Akkaraju

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Srinivas Akkaraju are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Junlin Ho

General Counsel

n/a

−18K

n/a

Vesting, gifts, unvested awards and holding lines for Junlin Ho

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Junlin Ho are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
77,145	$15.75	Feb 12, 2034	$3.0M
42,855	$35.15	Mar 10, 2035	$845K
11,429	$34.07	Jun 9, 2035	$238K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Caryn Parlavecchio

CHRO

n/a

−16K

n/a

Vesting, gifts, unvested awards and holding lines for Caryn Parlavecchio

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Caryn Parlavecchio are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
62,855	$15.75	Feb 12, 2034	$2.5M
31,430	$35.15	Mar 10, 2035	$620K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Mo Qatanani

Chief Scientific Officer

n/a

−189K

n/a

Vesting, gifts, unvested awards and holding lines for Mo Qatanani

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mo Qatanani are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
4,375	$26.05	Oct 26, 2031	$126K
961	$7.62	Oct 10, 2032	$45K
11,250	$10.00	Feb 13, 2033	$505K
47,143	$15.75	Feb 12, 2034	$1.8M
32,142	$35.15	Mar 10, 2035	$634K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Jing Marantz

Chief Medical Officer

n/a

−10K

n/a

Vesting, gifts, unvested awards and holding lines for Jing Marantz

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jing Marantz are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
130,000	$8.59	Nov 14, 2032	$6.0M
97,145	$15.75	Feb 12, 2034	$3.8M
45,715	$35.15	Mar 10, 2035	$902K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Tracey Sacco

Chief Commercial Officer

n/a

Vesting, gifts, unvested awards and holding lines for Tracey Sacco

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Tracey Sacco are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
65,715	$15.75	Feb 12, 2034	$2.6M
140,625	$10.00	Feb 13, 2033	$6.3M
37,145	$35.15	Mar 10, 2035	$733K
185,000	$10.00	Feb 13, 2033	$8.3M

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Michael Gilman

Director

n/a

−2.5K

n/a

Vesting, gifts, unvested awards and holding lines for Michael Gilman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Michael Gilman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Katie Peng

Director

n/a

−6.5K

n/a

Vesting, gifts, unvested awards and holding lines for Katie Peng

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Katie Peng are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
35,767	$14.82	Apr 9, 2034	$1.4M
6,000	$8.36	Jun 27, 2034	$279K
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Jeffrey Flier

Director

n/a

−3.1K

n/a

Vesting, gifts, unvested awards and holding lines for Jeffrey Flier

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jeffrey Flier are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Kristina Burow

Director

n/a

−3.1K

n/a

Vesting, gifts, unvested awards and holding lines for Kristina Burow

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kristina Burow are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Joshua Reed

Director

n/a

−3.1K

n/a

Vesting, gifts, unvested awards and holding lines for Joshua Reed

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Joshua Reed are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Richard Brudnick

Director

n/a

Vesting, gifts, unvested awards and holding lines for Richard Brudnick

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Richard Brudnick are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
18,000	$8.36	Jun 27, 2034	$837K
9,206	$30.46	May 22, 2035	$225K
4,310	$45.33	Jun 4, 2036	$41K

Estimate: options held × ($54.88 − strike price), using the most recent insider trade price on Form 4 (Jul 1, 2026), not a market close.

Holdings and share of stake for Scholar Rock Holding Corp are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$19.4M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $19.4M across 425,572 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $8.8M · 45%

55%

The lighter segment is sales with no plan disclosed in the filing ($10.6M), including tax-related sales outside a plan.

Taxes

$11.6M of sales (59.6%) cite tax obligations in their footnotes, $967K of them also under a plan. Example: Joshua Reed, Jul 1, 2026

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Mo Qatanani Chief Scientific Officer	189K	$8.6M	91%	44%	Dec 4, 2025 to Feb 23, 2026
David Hallal Chief Executive Officer, Director	88K	$4.0M	0%	20%	Jan 13, 2026 to Apr 16, 2026
Akshay Vaishnaw President of R&D, Director	33K	$1.5M	0%	8%	Jan 13, 2026 to Apr 16, 2026
Vikas Sinha Chief Financial Officer	27K	$1.2M	0%	6%	Jan 13, 2026 to Apr 16, 2026
Keith Woods Chief Operating Officer	27K	$1.2M	0%	6%	Jan 13, 2026 to Apr 16, 2026
Junlin Ho General Counsel	18K	$802K	0%	4%	Jan 16, 2026 to Feb 17, 2026
Caryn Parlavecchio CHRO	16K	$714K	0%	4%	Jan 16, 2026 to Feb 17, 2026
Jing Marantz Chief Medical Officer	10K	$451K	0%	2%	Jan 16, 2026 to Feb 17, 2026
Katie Peng Director	6.5K	$338K	100%	2%	Dec 16, 2025 to Jul 1, 2026
Jeffrey Flier Director	3.1K	$164K	100%	0.8%	Jul 1, 2026 to Jul 1, 2026
Joshua Reed Director	3.1K	$164K	100%	0.8%	Jul 1, 2026 to Jul 1, 2026
Kristina Burow Director	3.1K	$164K	100%	0.8%	Jul 1, 2026 to Jul 1, 2026
Michael Gilman Director	2.5K	$137K	100%	0.7%	Jul 1, 2026 to Jul 1, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$0	$0	$0	$0
Dec 2025	$6.2M	$6.2M	$0	$0
Jan 2026	$7.3M	$1.3M	$6.0M	$0
Feb 2026	$1.8M	$399K	$1.4M	$0
Mar 2026	$0	$0	$0	$0
Apr 2026	$3.1M	$0	$3.1M	$0
May 2026	$0	$0	$0	$0
Jun 2026	$0	$0	$0	$0
Jul 2026	$923K	$923K	$0	$0
Aug 2026	$0	$0	$0	$0
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Board members representing outside shareholders (2)Listed and sourced; not part of the management totals or the answer line

Directors whose reported holdings sit mostly in an investment fund or a corporate shareholder they represent, not in their own name, with beneficial ownership disclaimed except for their own financial interest. Listed and sourced here; not part of the management totals or the answer line. Shares a fund hands to its own investors are distributions, not sales.

Board member	Held Oct 16, 2025	Sold	Held Oct 16, 2026	Still held
Srinivas Akkaraju ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Srinivas Akkaraju are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Srinivas Akkaraju Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Srinivas Akkaraju are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)
Kristina Burow ! Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Kristina Burow are complete. Director	n/a	0	n/a	n/a
Vesting, gifts, unvested awards and holding lines for Kristina Burow Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kristina Burow are complete; balances and unit counts will be added when the check is finished. 0gifted (net of own trusts)

Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 1.8x the 5-year average. 13 insiders sold; the average is 6 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 16, 2026 Latest 12 months	426K	13	$19.4M
Oct 16, 2025 1 year earlier	486K	15	$17.6M
Oct 16, 2024 2 years earlier	546K	7	$13.0M
Oct 17, 2023 3 years earlier	3.3K	2	$22K
Oct 17, 2022 4 years earlier	78K	1	$2.8M
Oct 17, 2021 5 years earlier	73K	3	$3.9M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty16 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Scholar Rock Holding Corp are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology320 filings on record, 46 filed in the 12-month period, and how we read them

All 320 Forms 3, 4 and 5 on record for Scholar Rock Holding Corp (SEC CIK 1727196), filed from May 23, 2018 to Sep 25, 2026; 46 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (16)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Erin Moore	Mar 25, 2025	82,609 shares, last reported balance as of Mar 24, 2025
Edward Myles	Mar 12, 2025	111,345 shares, last reported balance as of Mar 10, 2025
Jay Backstrom	Mar 12, 2025	425,561 shares, last reported balance as of Mar 10, 2025
Amir Nashat	May 13, 2024	40,108 shares, last reported balance as of May 9, 2024
Amir Nashat	May 13, 2024	1,747,427 shares, last reported balance as of May 9, 2024
Samsara BioCapital GP, LLC	Oct 18, 2023	6,788,609 shares, last reported balance as of Oct 16, 2023
Nagesh Mahanthappa	Jun 21, 2022	860,982 shares, last reported balance as of Jun 16, 2022
Gregory Carven	Jun 21, 2022	128,208 shares, last reported balance as of Jun 16, 2022
Yung Chyung	Feb 15, 2022	258,496 shares, last reported balance as of Feb 14, 2022
Stuart Kingsley	Feb 3, 2021	42,000 shares, last reported balance as of Feb 1, 2021
Alan Buckler	Feb 10, 2020	157,628 shares, last reported balance as of May 23, 2018
Timothy Springer	Dec 12, 2019	3,043,840 shares, last reported balance as of Dec 10, 2019
Rhonda Chicko	Feb 4, 2019	No balance on record
Polaris Venture Management Co. VI, L.L.C.	May 31, 2018	2,832,706 shares, last reported balance as of May 29, 2018
ARCH Venture Fund VIII, L.P.	May 31, 2018	2,637,617 shares, last reported balance as of May 29, 2018
Elan Ezickson	May 31, 2018	322,451 shares, last reported balance as of May 23, 2018

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Scholar Rock Holding Corp insiders sold $19.4M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Outside holders, reported separately

Common questions

Is the Scholar Rock Holding Corp CEO selling stock?

Why are Scholar Rock Holding Corp insiders selling?

Are any Scholar Rock Holding Corp insiders buying?

The evidence

Taxes

Sales by month